EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Conferences
Olivotto, I; Ho, C; Jacoby, D; Lester, S; Roe, M; Wang, A; Tamby, J-F; Lambing, J; Lee, J; Zhang, D; Sehnert, A; Heitner, S
Published in: CIRCULATION
November 6, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 6, 2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Olivotto, I., Ho, C., Jacoby, D., Lester, S., Roe, M., Wang, A., … Heitner, S. (2018). EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. In CIRCULATION (Vol. 138).
Olivotto, Iacopo, Carolyn Ho, Daniel Jacoby, Steven Lester, Matthew Roe, Andrew Wang, Jean-Francois Tamby, et al. “EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy.” In CIRCULATION, Vol. 138, 2018.
Olivotto I, Ho C, Jacoby D, Lester S, Roe M, Wang A, et al. EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. In: CIRCULATION. 2018.
Olivotto, Iacopo, et al. “EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy.” CIRCULATION, vol. 138, 2018.
Olivotto I, Ho C, Jacoby D, Lester S, Roe M, Wang A, Tamby J-F, Lambing J, Lee J, Zhang D, Sehnert A, Heitner S. EXPLORER-HCM: Phase 3 Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. CIRCULATION. 2018.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 6, 2018
Volume
138
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology